NASDAQ
08.01.25
21:58 Uhr
7,680 US-Dollar
+0,010
+0,13 %
+0,13 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Stocks in Play: Profound Medical Corp. | - | Baystreet.ca | ||
| Mi | Profound Medical reports FY24 revenue above consensus | 1 | Seeking Alpha | ||
| Mi | Profound Medical Corp.: Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues | 52 | GlobeNewswire (Europe) | - Fourth quarter revenue growth estimated at 105% to 110% year-over-year - - Company to start reporting in accordance with U.S. GAAP and filing with the SEC on U.S. domestic forms - - Profound reminds... ► Artikel lesen | |
| Mi | Profound Medical Corp. - 8-K, Current Report | - | SEC Filings | ||
| Mo | Profound Medical Corp. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 30.12.24 | Profound Medical stock hits 52-week low at $6.87 amid market challenges | 1 | Investing.com | ||
| PROFOUND MEDICAL Aktie jetzt für 0€ handeln | |||||
| 30.12.24 | Profound Medical-Aktie erreicht 52-Wochen-Tief bei 6,87 US-Dollar | 2 | Investing.com Deutsch | ||
| 16.12.24 | Profound Medical Corp. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 13.12.24 | Profound Medical stock hits 52-week low at $7.01 amid market shifts | 2 | Investing.com | ||
| 12.12.24 | Profound Medical keeps "Strong Buy" rating at Raymond James | 2 | Cantech Letter | ||
| 10.12.24 | Profound Medical Corp (2): Profound Medical closes $40.25-million (U.S.) financing | 2 | Stockwatch | ||
| 10.12.24 | Profound Medical Corp.: Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares | 1 | GlobeNewswire (USA) | ||
| 09.12.24 | Profound Medical Corp (2): Profound Medical to list 4,666,700 more shares on TSX | 2 | Stockwatch | ||
| 06.12.24 | Profound Medical prices $35M public offering; shares down | 2 | Seeking Alpha | ||
| 06.12.24 | Profound Medical prices $35M offering | 1 | MassDevice | ||
| 06.12.24 | Profound Medical Corp (2): Profound Medical prices $35M (U.S.) share offering | 1 | Stockwatch | ||
| 06.12.24 | Profound Medical Corp (2): Profound Medical to resume at 6:50 a.m. PT | 2 | Stockwatch | ||
| 06.12.24 | Profound Medical Corp (2): Profound Medical halted at the open | 1 | Stockwatch | ||
| 06.12.24 | Profound Medical Corp.: Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares | 2 | GlobeNewswire (USA) | ||
| 06.12.24 | Profound Medical Corp (2): Profound Medical arranges public offering | 1 | Stockwatch |
Seite:
1 2 3 Weiter >>
51 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 5,433 | -1,79 % | emeis announces €251m in disposals of real estate and operating assets since the beginning of October | Nearly €900 million in disposals completed since mid-2022 or secured to date Disposal of activities in Chile and the Czech Republic
Regulatory News:
emeis (Paris:EMEIS) today announced... ► Artikel lesen | |
| NANO-X IMAGING | 8,755 | 0,00 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| BUTTERFLY NETWORK | 4,015 | 0,00 % | Butterfly Network, Inc. - 8-K, Current Report | ||
| CARMAT | 1,074 | -0,19 % | CARMAT Delivers a Solid FY 2024 with 42 Implants of Its Aeson Artificial Heart and Anticipates Continued Strong Momentum in 2025 | Over 90 patients have received the Aeson® artificial heart since the first implant in 2013, including 42 in 2024.
2024 Sales of €7 million (a 2.5-fold increase vs 2023).
Cash burn... ► Artikel lesen | |
| TALKSPACE | 3,070 | -2,54 % | Talkspace More Widely Available | ||
| GOODRX | 4,280 | 0,00 % | Assessing GoodRx Holdings: Insights From 4 Financial Analysts | ||
| PROCEPT BIOROBOTICS | 86,43 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| JOINT CORP | 10,330 | 0,00 % | The Joint Corp. Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | SCOTTSDALE, Ariz., Oct. 15, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) ("The Joint or "the Company"), the nation's largest franchisor of chiropractic care through The Joint Chiropractic®... ► Artikel lesen | |
| MIMEDX | 8,840 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces Third Quarter 2024 Operating and Financial Results | Net Sales of $84 million Grew 3% Year-Over-Year for the Third QuarterThird Quarter GAAP Net Income and Earnings Per Share were $8 Million and $0.05, RespectivelyThird Quarter Adjusted EBITDA was $18... ► Artikel lesen | |
| HYPERFINE | 0,999 | 0,00 % | Hyperfine, Inc.: Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets | Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health... ► Artikel lesen | |
| BIOMERICA | 0,328 | -8,86 % | Biomerica, Inc.: Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements | IRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a leading global provider of advanced medical diagnostics, announced that it has been granted an additional 180-day... ► Artikel lesen | |
| ATRICURE | 33,670 | +2,97 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
| PROGYNY | 18,230 | 0,00 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
| PROPHASE LABS | 0,574 | 0,00 % | ProPhase Labs-Aktie erreicht 52-Wochen-Tief bei 0,61 US-Dollar | ||
| LIFEMD | 5,100 | 0,00 % | LifeMD CEO Justin Schreiber verkauft Aktien im Wert von 129.667 US-Dollar |
PROFOUND MEDICAL CORP gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +0,13 % bei einem Aktienkurs von 7,680 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROFOUND MEDICAL CORP finden Sie auf Wallstreet Online.
